Mira Pharmaceuticals, Inc. (MIRA) SEC Filings — 2025

Filings

• Mira Pharmaceuticals, Inc. 8-K Filing — 8-K · Dec 22, 2025
• Mira Pharmaceuticals, Inc. 8-K Filing — 8-K · Dec 5, 2025
• MIRA Pharma's Q3 Loss Widens on Deemed Dividend, Acquires SKNY — 10-Q · Nov 13, 2025
• Mira Pharmaceuticals Files 8-K: Other Event — 8-K · Oct 23, 2025
• Mira Pharmaceuticals Files 8-K — 8-K · Oct 16, 2025
• Mira Pharmaceuticals Files 8-K: Other Events — 8-K · Oct 15, 2025
• Mira Pharmaceuticals Completes Acquisition, Reports Key Agreements — 8-K · Sep 30, 2025
• Mira Pharmaceuticals Files 8-K — 8-K · Sep 22, 2025
• Mira Pharmaceuticals Files 8-K for Other Events — 8-K · Sep 15, 2025
• Mira Pharmaceuticals Files 8-K on Officer/Director Changes — 8-K · Sep 11, 2025
• Mira Pharmaceuticals Files 8-K for Other Events — 8-K · Aug 19, 2025
• Mira Pharmaceuticals Files 10-Q for Q2 2025 — 10-Q · Aug 14, 2025
• Mira Pharmaceuticals Changes Principal Executive Offices — 8-K · Aug 12, 2025
• Mira Pharmaceuticals Files Additional Proxy Materials — DEFA14A · Aug 8, 2025
• Mira Pharmaceuticals Files 8-K — 8-K · Jul 29, 2025
• Mira Pharmaceuticals Files 8-K — 8-K · Jul 28, 2025
• Mira Pharmaceuticals Files 8-K — 8-K · Jul 10, 2025
• Mira Pharmaceuticals to Acquire BioGenetics, Inc. — 8-K · Jul 8, 2025
• Mira Pharmaceuticals Updates Office and Contact Info — 8-K · Jul 2, 2025
• Mira Pharmaceuticals Files 8-K — 8-K · Jun 30, 2025
• Mira Pharmaceuticals Files 8-K: Other Event — 8-K · Jun 24, 2025
• Mira Pharmaceuticals Files 8-K — 8-K · Jun 17, 2025
• Mira Pharmaceuticals Updates Office and Contact Info — 8-K · May 28, 2025
• Mira Pharmaceuticals Reports Material Agreement, Officer Changes — 8-K · May 21, 2025
• Mira Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 14, 2025
• Mira Pharmaceuticals Updates Office and Contact Info — 8-K · May 8, 2025
• Mira Pharmaceuticals Relocates HQ — 8-K · May 6, 2025
• Mira Pharmaceuticals Relocates Executive Offices — 8-K · Apr 23, 2025
• Mira Pharmaceuticals Files 2024 10-K Amendment — 10-K/A · Apr 17, 2025
• Mira Pharmaceuticals Files 8-K — 8-K · Apr 16, 2025
• Mira Pharmaceuticals Files 10-K/A Amendment — 10-K/A · Apr 15, 2025
• Mira Pharmaceuticals Faces Delisting Concerns — 8-K · Apr 11, 2025
• Mira Pharmaceuticals Files 8-K — 8-K · Apr 1, 2025
• Mira Pharmaceuticals, Inc. 10-K Filing — 10-K · Mar 28, 2025
• Mira Pharmaceuticals Enters Material Definitive Agreement — 8-K · Mar 24, 2025
• Mira Pharmaceuticals Relocates Principal Executive Offices — 8-K · Mar 13, 2025
• Mira Pharmaceuticals Relocates HQ — 8-K · Mar 4, 2025